Article
Functionally Confirmed Compound Heterozygous ADAM17 Missense Loss-of-function Variants…
· 2021 · Imoto I, Saito M, Suga K, Kohmoto T, Otsu M, Horiuchi K, Nakayama H, Higashiyama S, Sugimoto M, Sasaki A, Homma Y, Shono M, Nakagawa R, Hayabuchi Y, Tange S, Kagami S, Masuda K.
Key facts
| Title | Functionally Confirmed Compound Heterozygous ADAM17 Missense Loss-of-function Variants Cause Neonatal Inflammatory Skin and Bowel Disease 1 |
|---|---|
| First author | Imoto I, Saito M, Suga K, Kohmoto T, Otsu M, Horiuchi K, Nakayama H, Higashiyama S, Sugimoto M, Sasaki A, Homma Y, Shono M, Nakagawa R, Hayabuchi Y, Tange S, Kagami S, Masuda K. |
| Published | Feb 17, 2021 |
| DOI | 10.21203/rs.3.rs-206853/v1 |
| Devices mentioned | 206853 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1